BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6602217)

  • 1. A comparative study of the clinical use of four placental proteins in the third trimester.
    Obiekwe BC; Chard T
    J Perinat Med; 1983; 11(2):121-6. PubMed ID: 6602217
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pregnancy-specific beta 1-glycoprotein, HCG alpha subunit, alpha fetoproteins and HPL in fetal hypotrophy].
    Ruseva R; Marinov B; Milkov V; Milanov S
    Akush Ginekol (Sofiia); 1984; 23(4):315-20. PubMed ID: 6207743
    [No Abstract]   [Full Text] [Related]  

  • 3. The value of measurement of pregnancy-specific proteins in twin pregnancies.
    Jandial V; Horne CH; Glover RG; Nisbet AD; Campbell DM; MacGillivray I
    Acta Genet Med Gemellol (Roma); 1979; 28(4):319-25. PubMed ID: 318010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circadian variation of circulating levels of four placental proteins.
    Houghton DJ; Newnham JP; Lo K; Rice A; Chard T
    Br J Obstet Gynaecol; 1982 Oct; 89(10):831-5. PubMed ID: 6982066
    [No Abstract]   [Full Text] [Related]  

  • 5. Interrelationships of human chorionic gonadotropin, human placental lactogen, and pregnancy-specific beta 1-glycoprotein throughout normal human gestation.
    Braunstein GD; Rasor JL; Engvall E; Wade ME
    Am J Obstet Gynecol; 1980 Dec; 138(8):1205-13. PubMed ID: 6969545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in some of the body fluid hormone levels currently used for endocrine monitoring during the third trimester of pregnancy.
    Pedretti E; Capitanio GL; Casadio M; Lanera P; Conte N
    J Perinat Med; 1981; 9(1):40-7. PubMed ID: 6971326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of high-risk pregnancy by the routine measurement of pregnancy-specific beta 1-glycoprotein.
    Grudzinskas JG; Gordon YB; Menabawey M; Lee JN; Wadsworth J; Chard T
    Am J Obstet Gynecol; 1983 Sep; 147(1):10-2. PubMed ID: 6604456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of human placental lactogen and pregnancy-specific beta 1-glycoprotein in breast cancer.
    Monteiro JC; Biswas S; Al-Awqati MA; Greening WP; McKinna JA; Neville AM
    Br J Cancer; 1982 Aug; 46(2):279-82. PubMed ID: 6983887
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pregnancy proteins--clinical relevancy in late pregnancy].
    Bellmann O
    Gynakologe; 1983 Sep; 16(3):132-47. PubMed ID: 6196259
    [No Abstract]   [Full Text] [Related]  

  • 10. The relation between the concentration of placental specific proteins in retroplacental and peripheral blood.
    Grudzinskas JG; Menabawey M; Wiley BA; Teisner B; Chard T
    Br J Obstet Gynaecol; 1979 Nov; 86(11):891-3. PubMed ID: 92339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of placental protein 5, placental lactogen and pregnancy-specific beta 1 glycoprotein in mid-trimester as a predictor of outcome of pregnancy.
    Salem HT; Lee JN; Seppälä M; Vaara L; Aula P; Al-Ani AT; Chard T
    Br J Obstet Gynaecol; 1981 Apr; 88(4):371-4. PubMed ID: 6971651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pre-eclampsia and placental hormones (author's transl)].
    Weber H; Heller S; Seulen P
    Geburtshilfe Frauenheilkd; 1980 Apr; 40(4):339-43. PubMed ID: 6966596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [SP1-glycoprotein and beta-HCG during the first trimester in physiological, ectopic and abortive pregnancies].
    Fanizza G; Pizza M; Ranieri DM
    Ann Ostet Ginecol Med Perinat; 1987; 108(2):77-82. PubMed ID: 3498424
    [No Abstract]   [Full Text] [Related]  

  • 14. [The laboratory in monitoring high-risk pregnancy].
    Radillo L; Cociancich G; D'Atri A; Ghionni A; Mangiarotti M
    Quad Sclavo Diagn; 1981 Jun; 17(2):164-71. PubMed ID: 6973774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Do pregnancy proteins have prospective significance? (SP-1, HPL and PP-5)].
    Tatra G; Lüben G; Nasr F
    Geburtshilfe Frauenheilkd; 1985 Jun; 45(6):363-6. PubMed ID: 3874806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating placental proteins in pregnancies complicated by RH isoimmunization.
    Lee JN; Huang SC; Ouyang PC; Chard T
    Obstet Gynecol; 1984 Jul; 64(1):131-2. PubMed ID: 6429588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The serum levels of human alpha-fetoprotein, AFP, choriogonadotropin, hCG, placental lactogen, hPL, and pregnancy-specific beta 1-glycoprotein, SP1, are of no clinical significance in colorectal carcinoma.
    Szymendera JJ; Kaminska JA; Nowacki MP; Szawłowski AW; Gadek A
    Eur J Cancer Clin Oncol; 1981 Sep; 17(9):1047-52. PubMed ID: 6173222
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
    Zhang WY
    Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation of the trophoblastic beta 1-globulin and chorionic gonadotropin indices and the clinical course of the disease in uterine chorionepithelioma].
    Zhordina KI; Sokolov AV; Kadagidze ZG; Molodyk AA
    Akush Ginekol (Mosk); 1981 Jul; (7):55-6. PubMed ID: 6975579
    [No Abstract]   [Full Text] [Related]  

  • 20. Human placental lactogen, pregnancy-specific beta-1-glycoprotein and alpha-fetoprotein in serum in threatened abortion.
    Hertz JB; Schultz-Larsen P
    Int J Gynaecol Obstet; 1983 Apr; 21(2):111-7. PubMed ID: 6193015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.